Cancer plasticity drives tumor progression and treatment resistance. Research identifies a high-plasticity cell state (HPCS) in lung adenocarcinoma that enables diverse cellular transitions. Targeting the HPCS or its molecular programs may improve clinical cancer management. Powered by <a href="https://firstory.me/zh">Firstory Hosting</a>

Cancer plasticity drives tumor progression and treatment resistance. Research identifies a high-plasticity cell state (HPCS) in lung adenocarcinoma that enables diverse cellular transitions. Targeting the HPCS or its molecular programs may improve clinical cancer management. Powered by Firstory Hosting

Cancer plasticity drives tumor progression and treatment resistance. Research identifies a high-plasticity cell state (HPCS) in lung adenocarcinoma that enables diverse cellular transitions. Targeting the HPCS or its molecular programs may improve clinical cancer management. Powered by <a href="https://firstory.me/zh" rel="noopener noreferrer">Firstory Hosting</a>

HPCS: A Dynamic Hub for Lung Cancer Growth and Resistance

It's a podcast discussing recent exciting scientific findings in biology and medicine. Powered by <a href="https://firstory.me/zh">Firstory Hosting</a>

Science

Medicine

Health & Fitness

Education

Life Sciences

It's a podcast discussing recent exciting scientific findings in biology and medicine. Powered by Firstory Hosting

It's a podcast discussing recent exciting scientific findings in biology and medicine. Powered by <a href="https://firstory.me/zh" rel="noopener noreferrer">Firstory Hosting</a>

Share HPCS: A Dynamic Hub for Lung Cancer Growth and Resistance

Sign up to save your podcasts

HPCS: A Dynamic Hub for Lung Cancer Growth and Resistance

HPCS: A Dynamic Hub for Lung Cancer Growth and Resistance